Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus

R. D. Sontheimer, P. Stastny, J. N. Gilliam

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

We have identified a clinically distinct subset of lupus erythematosus patients marked by the presence of a histologically proven, nonscarring variety of cutaneous LE (subacute cutaneous LE) in which there is a very high frequency of the human leukocyte antigens (HLA) B8 and DR3. Differences in the configuration of their skin lesions allowed a separation of the patients into two clinical subgroups; annular and papulosquamous. HLA-B8 was increased in the annular subgroup (81%, corrected P (Pc) < 0.007) and combined group (65%, Pc < 0.004). HLA-DR3 was present in all 11 of the annular patients (100%, Pc < 0.00008). In addition, HLA-DR3 was present in increased frequencies in the papulosquamous subgroup (60%, Pc < 0.04) and combined group (77%, Pc < 0.00008). Thus, HLA-DR3 positive individuals have a relative risk of 10.8 for developing subacute cutaneous LE of either type and an even greater relative risk (67.1) for the annular variety. The HLA phenotype A1, B8, DR3 was also found more commonly in the annular (73%, P < 0.00008) and combined patient group (46%, P < 0.004). These HLA associations, which are stronger than ever before reported for any form of LE, did not result from the concurrent presence of subclinical Sjogren's syndrome. Thus, subacute cutaneous LE can now be added to the growing list of HLA-B8, DR3-associated diseases that have autoimmune infections.

Original languageEnglish (US)
Pages (from-to)312-316
Number of pages5
JournalJournal of Clinical Investigation
Volume67
Issue number1
StatePublished - 1981

Fingerprint

Cutaneous Lupus Erythematosus
Histocompatibility Antigens
HLA Antigens
Skin
Sjogren's Syndrome
Autoimmune Diseases
Phenotype

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. / Sontheimer, R. D.; Stastny, P.; Gilliam, J. N.

In: Journal of Clinical Investigation, Vol. 67, No. 1, 1981, p. 312-316.

Research output: Contribution to journalArticle

Sontheimer, RD, Stastny, P & Gilliam, JN 1981, 'Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus', Journal of Clinical Investigation, vol. 67, no. 1, pp. 312-316.
Sontheimer, R. D. ; Stastny, P. ; Gilliam, J. N. / Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus. In: Journal of Clinical Investigation. 1981 ; Vol. 67, No. 1. pp. 312-316.
@article{a7352a7bb469498ea12e37e499933217,
title = "Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus",
abstract = "We have identified a clinically distinct subset of lupus erythematosus patients marked by the presence of a histologically proven, nonscarring variety of cutaneous LE (subacute cutaneous LE) in which there is a very high frequency of the human leukocyte antigens (HLA) B8 and DR3. Differences in the configuration of their skin lesions allowed a separation of the patients into two clinical subgroups; annular and papulosquamous. HLA-B8 was increased in the annular subgroup (81{\%}, corrected P (Pc) < 0.007) and combined group (65{\%}, Pc < 0.004). HLA-DR3 was present in all 11 of the annular patients (100{\%}, Pc < 0.00008). In addition, HLA-DR3 was present in increased frequencies in the papulosquamous subgroup (60{\%}, Pc < 0.04) and combined group (77{\%}, Pc < 0.00008). Thus, HLA-DR3 positive individuals have a relative risk of 10.8 for developing subacute cutaneous LE of either type and an even greater relative risk (67.1) for the annular variety. The HLA phenotype A1, B8, DR3 was also found more commonly in the annular (73{\%}, P < 0.00008) and combined patient group (46{\%}, P < 0.004). These HLA associations, which are stronger than ever before reported for any form of LE, did not result from the concurrent presence of subclinical Sjogren's syndrome. Thus, subacute cutaneous LE can now be added to the growing list of HLA-B8, DR3-associated diseases that have autoimmune infections.",
author = "Sontheimer, {R. D.} and P. Stastny and Gilliam, {J. N.}",
year = "1981",
language = "English (US)",
volume = "67",
pages = "312--316",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "1",

}

TY - JOUR

T1 - Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus

AU - Sontheimer, R. D.

AU - Stastny, P.

AU - Gilliam, J. N.

PY - 1981

Y1 - 1981

N2 - We have identified a clinically distinct subset of lupus erythematosus patients marked by the presence of a histologically proven, nonscarring variety of cutaneous LE (subacute cutaneous LE) in which there is a very high frequency of the human leukocyte antigens (HLA) B8 and DR3. Differences in the configuration of their skin lesions allowed a separation of the patients into two clinical subgroups; annular and papulosquamous. HLA-B8 was increased in the annular subgroup (81%, corrected P (Pc) < 0.007) and combined group (65%, Pc < 0.004). HLA-DR3 was present in all 11 of the annular patients (100%, Pc < 0.00008). In addition, HLA-DR3 was present in increased frequencies in the papulosquamous subgroup (60%, Pc < 0.04) and combined group (77%, Pc < 0.00008). Thus, HLA-DR3 positive individuals have a relative risk of 10.8 for developing subacute cutaneous LE of either type and an even greater relative risk (67.1) for the annular variety. The HLA phenotype A1, B8, DR3 was also found more commonly in the annular (73%, P < 0.00008) and combined patient group (46%, P < 0.004). These HLA associations, which are stronger than ever before reported for any form of LE, did not result from the concurrent presence of subclinical Sjogren's syndrome. Thus, subacute cutaneous LE can now be added to the growing list of HLA-B8, DR3-associated diseases that have autoimmune infections.

AB - We have identified a clinically distinct subset of lupus erythematosus patients marked by the presence of a histologically proven, nonscarring variety of cutaneous LE (subacute cutaneous LE) in which there is a very high frequency of the human leukocyte antigens (HLA) B8 and DR3. Differences in the configuration of their skin lesions allowed a separation of the patients into two clinical subgroups; annular and papulosquamous. HLA-B8 was increased in the annular subgroup (81%, corrected P (Pc) < 0.007) and combined group (65%, Pc < 0.004). HLA-DR3 was present in all 11 of the annular patients (100%, Pc < 0.00008). In addition, HLA-DR3 was present in increased frequencies in the papulosquamous subgroup (60%, Pc < 0.04) and combined group (77%, Pc < 0.00008). Thus, HLA-DR3 positive individuals have a relative risk of 10.8 for developing subacute cutaneous LE of either type and an even greater relative risk (67.1) for the annular variety. The HLA phenotype A1, B8, DR3 was also found more commonly in the annular (73%, P < 0.00008) and combined patient group (46%, P < 0.004). These HLA associations, which are stronger than ever before reported for any form of LE, did not result from the concurrent presence of subclinical Sjogren's syndrome. Thus, subacute cutaneous LE can now be added to the growing list of HLA-B8, DR3-associated diseases that have autoimmune infections.

UR - http://www.scopus.com/inward/record.url?scp=0019448999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019448999&partnerID=8YFLogxK

M3 - Article

C2 - 7451656

AN - SCOPUS:0019448999

VL - 67

SP - 312

EP - 316

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 1

ER -